To access this element change to forms mode OFF
Grant Award View - GA85469
Targeting SARS-CoV-2 using Stealth nanoparticles loaded with gene...
GA ID:
GA85469
Agency:
Department of Health and Aged Care
Approval Date:
29-May-2020
Publish Date:
23-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2021
Value (AUD):
$317,694.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 19/20 1.1 Health Policy Research and Analysis
Grant Program:
2020_MRFF_Anti_Viral_COVID19
Grant Activity:
Targeting SARS-CoV-2 using Stealth nanoparticles loaded with gene silencing siRNAs
Purpose:
We have developed technology that turns off respiratory virus genes, resulting in a 99.9 percent reduction in virus growth in animal models. We have already used it against Hendravirus, RSV, and hMPV. These stealth nanoparticles, made from FDA approved materials, are able to deliver to the infected lung cells via the blood stream, bypassing the inflamed airway that blocks other medicines from working. Here we will explore this for COVD19 virus.
GO ID:
GO Title:
MRFF – 2020 Antiviral Development for COVID-19 Grant Opportunity
Internal Reference ID:
MRF2001931
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Griffith University
Recipient ABN:
78 106 094 461
Grant Recipient Location
Suburb:
Nathan
Town/City:
Nathan
Postcode:
4111
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES